American Journal of Cardiology
Volume 99, Issue 7 , Pages 890-895 , 1 April 2007

Serum Complement C3/C4 Ratio, a Novel Marker for Recurrent Cardiovascular Events

  • Anil Palikhe, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    • Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland
    • ,
  • Juha Sinisalo, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Mikko Seppänen, MD

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Heikki Haario, PhD

      Affiliations

    • Laboratory of Applied Mathematics, Lappeenranta University of Technology, Lappeenranta, Finland.
    • ,
  • Seppo Meri, MD, PhD

      Affiliations

    • Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland
    • ,
  • Ville Valtonen, MD, PhD

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Markku S. Nieminen, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Marja-Liisa Lokki, PhD

      Affiliations

    • Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland
    • Corresponding Author InformationCorresponding author: Tel: 358-9-191-26614; fax: 358-9-241-1227.

Received 29 August 2006 ,Revised 7 November 2006 ,Accepted 7 November 2006.

References 

  1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695
  2. Walport MJ. Complement (First of two parts). N Engl J Med. 2001;344:1058–1066
  3. Walport MJ. Complement (Second of two parts). N Engl J Med. 2001;344:1140–1144
  4. Schifferli JA, Ng YC, Peters DK. The role of complement and its receptor in the elimination of immune complexes. N Engl J Med. 1986;315:488–495
  5. Wissler RW, Vesselinovitch D, Ko C. The effects of circulating immune complexes on atherosclerotic lesions in experimental animals and in younger and older humans. Transplant Proc. 1989;21:3707–3708
  6. Wissler RW. Update on the pathogenesis of atherosclerosis. Am J Med. 1991;91(suppl):3S–9S
  7. Qiao JH, Castellani LW, Fishbein MC, Lusis AJ. Immune-complex–mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice. Arterioscler Thromb. 1993;13:932–943
  8. Yasojima K, Schwab C, McGeer EG, McGeer PL. Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ Res. 1998;83:860–869
  9. Ciurana CL, Zwart B, van Mierlo G, Hack CE. Complement activation by necrotic cells in normal plasma environment compares to that by late apoptotic cells and involves predominantly IgM. Eur J Immunol. 2004;34:2609–2619
  10. Muscari A, Bozzoli C, Puddu GM, Sangiorgi Z, Dormi A, Rovinetti C, et al. Association of serum C3 levels with the risk of myocardial infarction. Am J Med. 1995;98:357–364
  11. Szeplaki G, Prohaszka Z, Duba J, Rugonfalvi-Kiss S, Karadi I, Kokai M, et al. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis. 2004;177:383–389
  12. Onat A, Uzunlar B, Hergenc G, Yazici M, Sari I, Uyarel H, et al. Cross-sectional study of complement C3 as a coronary risk factor among men and women. Clin Sci (Lond). 2005;108:129–135
  13. Szalai C, Fust G, Duba J, Kramer J, Romics L, Prohaszka Z, et al. Association of polymorphisms and allelic combinations in the tumour necrosis factor-alpha–complement MHC region with coronary artery disease. J Med Genet. 2002;39:46–51
  14. Kramer J, Rajczy K, Hegyi L, Fulop T, Mohacsi A, Mezei Z, et al. C4B*Q0 allotype as risk factor for myocardial infarction. BMJ. 1994;309:313–314
  15. Arason GJ, Kramer J, Bodvarsson S, Sigurdarson ST, Sigurdsson G, Fust G, et al. Increased frequency of C4B null alleles in Icelandic patients with coronary disease. Mol Immunol. 1998;35:412
  16. Sinisalo J, Mattila K, Valtonen V, Anttonen O, Juvonen J, Melin J, et al. Effect of 3 months of antimicrobial treatment with clarithromycin in acute non–q-wave coronary syndrome. Circulation. 2002;105:1555–1560
  17. Marcus D, Alper CA. Methods for allotyping complement proteins. In:  Rose NR,  Friedman H,  Fahey JL editor. Manual of Clinical Laboratory Immunology. 3rd Ed.. Washington, DC: American Society for Microbiology; 1986;p. 185–196
  18. Schorlemmer HU. The role of complement in the function of the monocyte-macrophage system. In:  Schmalzl F,  Hahn D,  Schaeffer HE editor. Haematology and Blood Transfusion (Disorders of the Monocyte Macrophage System). New York: Springer-Verlag; 1981;p. 59–71
  19. Nielsen CH, Fischer EM, Leslie RG. The role of complement in the acquired immune response. Immunology. 2000;100:4–12
  20. Nielsen CH, Leslie RG. Complement’s participation in acquired immunity. J Leukoc Biol. 2002;72:249–261
  21. Crawford K, Alper CA. Genetics of the complement system. Rev Immunogenet. 2000;2:323–338
  22. Cox BJ, Robins DM. Tissue-specific variation in C4 and Slp gene regulation. Nucleic Acids Res. 1988;16:6857–6870
  23. Cole FS, Matthews WJ, Marino JT, Gash DJ, Colten HR. Control of complement synthesis and secretion in bronchoalveolar and peritoneal macrophages. J Immunol. 1980;125:1120–1124
  24. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–454
  25. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal. 2004;18:1–8

 This study was funded by the University of Helsinki Foundation, Helsinki; the Finnish-Norwegian Medical Foundation, Helsinki; the Aarne Koskelo Foundation, Helsinki; the Finnish Foundation for Cardiovascular Research, Helsinki; the Helsinki University Central Hospital Research Funds (EVO), Helsinki; and the Finnish Red Cross Blood Transfusion Service Research Fund, Helsinki, Finland.

PII: S0002-9149(06)02486-6

doi: 10.1016/j.amjcard.2006.11.034

American Journal of Cardiology
Volume 99, Issue 7 , Pages 890-895 , 1 April 2007

Article Tools

* Image Usage & Resolution